These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3057 related articles for article (PubMed ID: 28012440)

  • 21. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATP2B3 Inhibition Alleviates Erastin-Induced Ferroptosis in HT-22 Cells through the P62-KEAP1-NRF2-HO-1 Pathway.
    Guo S; Zhong A; Zhang D; Gao J; Ni Y; Zhao R; Ma W
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells.
    Liang Z; Zhao W; Li X; Wang L; Meng L; Yu R
    Biochem Biophys Res Commun; 2021 Sep; 569():79-85. PubMed ID: 34237431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arenobufagin regulates the p62-Keap1-Nrf2 pathway to induce autophagy-dependent ferroptosis in HepG2 cells.
    Yang Y; Liu C; Wang M; Cheng H; Wu H; Luo S; Zhang M; Duan X; Li Q
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4895-4909. PubMed ID: 38165425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer.
    Roh JL; Kim EH; Park JY; Kim JW; Kwon M; Lee BH
    Oncotarget; 2014 Oct; 5(19):9227-38. PubMed ID: 25193861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferrostatin-1 alleviates angiotensin II (Ang II)- induced inflammation and ferroptosis in astrocytes.
    Li S; Zhou C; Zhu Y; Chao Z; Sheng Z; Zhang Y; Zhao Y
    Int Immunopharmacol; 2021 Jan; 90():107179. PubMed ID: 33278745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
    Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
    J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unlocking the anticancer activity of gambogic acid: a shift towards ferroptosis via a GSH/Trx dual antioxidant system.
    Lan J; Liu L; Zhao W; Li Z; Zeng R; Fang S; Chen L; Shen Y; Wei H; Zhang T; Ding Y
    Free Radic Biol Med; 2024 Jun; 218():26-40. PubMed ID: 38570172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Nrf2 on tumour growth and drug sensitivity in oncogenic K-ras-transformed cells in vitro and in vivo.
    Shao J; Glorieux C; Liao J; Chen P; Lu W; Liang Z; Wen S; Hu Y; Huang P
    Free Radic Res; 2018 Jun; 52(6):661-671. PubMed ID: 29621903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin.
    Roh JL; Kim EH; Park JY; Kim JW
    Mol Cancer Ther; 2015 Aug; 14(8):1907-15. PubMed ID: 26063766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer.
    Lou JS; Zhao LP; Huang ZH; Chen XY; Xu JT; Tai WC; Tsim KWK; Chen YT; Xie T
    Phytomedicine; 2021 Jan; 80():153370. PubMed ID: 33113504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ropivacaine prompts ferroptosis to enhance the cisplatin-sensitivity of human colorectal cancer through SIRT1/Nrf2 signaling pathway.
    Zeng L; Zhao W; Han T; Qing F; He Z; Zhao Q; Luo A; Hu P; Ding X; Zhang Z
    Chem Biol Interact; 2024 Sep; 400():111163. PubMed ID: 39053794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells.
    Han L; Li L; Wu G
    Mol Cell Probes; 2022 Aug; 64():101821. PubMed ID: 35490795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway.
    Chian S; Li YY; Wang XJ; Tang XW
    Asian Pac J Cancer Prev; 2014; 15(6):2911-6. PubMed ID: 24761924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fucoxanthin Induces Ferroptosis in Cancer Cells via Downregulation of the Nrf2/HO-1/GPX4 Pathway.
    Du HF; Wu JW; Zhu YS; Hua ZH; Jin SZ; Ji JC; Wang CS; Qian GY; Jin XD; Ding HM
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer.
    Shin D; Lee J; You JH; Kim D; Roh JL
    Redox Biol; 2020 Feb; 30():101418. PubMed ID: 31931284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of ferroptosis by HO-1 contributes to retinal degeneration in mice with defective clearance of all-trans-retinal.
    Chen C; Yang K; He D; Yang B; Tao L; Chen J; Wu Y
    Free Radic Biol Med; 2023 Jan; 194():245-254. PubMed ID: 36509314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation.
    Li Z; Mo RL; Gong JF; Han L; Wang WF; Huang DK; Xu JG; Sun YJ; Chen S; Han GC; Sun DQ
    Phytomedicine; 2024 Jul; 129():155661. PubMed ID: 38677269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 153.